China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,288 | 1,539 | 1,188 | 1,185 | N/A |
| Depreciation Amortization | 332 | 181 | 129 | 99 | N/A |
| Income taxes - deferred | -102 | -8 | -6 | N/A | N/A |
| Accounts receivable | 104 | -1,811 | 384 | -943 | N/A |
| Accounts payable and accrued liabilities | 302 | -567 | 967 | -1,472 | N/A |
| Other Working Capital | 1,947 | -1,563 | 609 | -991 | N/A |
| Other Operating Activity | 8,639 | 2,468 | -1,351 | 2,415 | 0 |
| Operating Cash Flow | $934 | $239 | $1,920 | $293 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -407 | -599 | -1,030 | -179 | N/A |
| Purchase Sale Intangibles | N/A | -11 | -21 | -7 | N/A |
| Other Investing Activity | -5,090 | -11 | -21 | -7 | 0 |
| Investing Cash Flow | $-5,497 | $-610 | $-1,051 | $-186 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -39 | 70 | N/A | N/A | N/A |
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,157 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 6,491 | N/A | N/A | N/A |
| Other Financing Activity | -5,780 | 2,482 | -314 | -51 | 0 |
| Financing Cash Flow | $3,024 | $9,042 | $-314 | $-51 | $N/A |
| Exchange Rate Effect | -467 | -37 | 37 | -2 | N/A |
| Beginning Cash Position | 9,292 | 658 | 66 | 11 | N/A |
| End Cash Position | 7,287 | 9,292 | 658 | 66 | N/A |
| Net Cash Flow | $-2,005 | $8,634 | $592 | $54 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 934 | 239 | 1,920 | 293 | N/A |
| Capital Expenditure | -407 | -599 | -1,030 | -179 | N/A |
| Free Cash Flow | 528 | -360 | 891 | 114 | 0 |